Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 275

1.

A review of cutaneous lupus erythematosus: improving outcomes with a multidisciplinary approach.

Jarrett P, Werth VP.

J Multidiscip Healthc. 2019 May 31;12:419-428. doi: 10.2147/JMDH.S179623. eCollection 2019. Review.

2.

Evaluating important change in cutaneous disease activity as an efficacy measure for clinical trials in dermatomyositis.

Ahmed S, Chakka S, Concha J, Krain R, Feng R, Werth VP.

Br J Dermatol. 2019 Jun 17. doi: 10.1111/bjd.18223. [Epub ahead of print]

PMID:
31206600
3.

Management of autoimmune blistering diseases in pregnancy and the neonate.

Krain RL, Chen KL, Werth VP.

G Ital Dermatol Venereol. 2019 Jun 12. doi: 10.23736/S0392-0488.19.06375-2. [Epub ahead of print]

PMID:
31195784
4.

Understanding cutaneous lupus erythematosus: a step forward.

Albrecht J, Werth VP.

Br J Dermatol. 2019 Jun;180(6):1292-1293. doi: 10.1111/bjd.17911. No abstract available.

PMID:
31157430
5.

Utilization Patterns and Performance of Commercial Myositis Autoantibody Panels in Routine Clinical Practice.

Gandiga PC, Zhang J, Sangani S, Thomas P, Werth VP, George MD.

Br J Dermatol. 2019 May 17. doi: 10.1111/bjd.18133. [Epub ahead of print]

PMID:
31102270
6.

Geospatial Correlation of Amyopathic Dermatomyositis With Fixed Sources of Airborne Pollution: A Retrospective Cohort Study.

Pearson DR, Werth VP.

Front Med (Lausanne). 2019 Apr 24;6:85. doi: 10.3389/fmed.2019.00085. eCollection 2019.

7.
8.

Developing classification criteria for skin-predominant dermatomyositis: the Delphi process.

Concha JSS, Pena S, Gaffney RG, Patel B, Tarazi M, Kushner CJ, Merola JF, Fiorentino D, Dutz JP, Goodfield M, Nyberg F, Volc-Platzer B, Fujimoto M, Ang CC; Skin Myositis Delphi Group, Werth VP.

Br J Dermatol. 2019 May 3. doi: 10.1111/bjd.18096. [Epub ahead of print]

PMID:
31049930
9.
10.

Blood plasma versus serum: which is right for sampling circulating membrane microvesicles in human subjects?

Liu ML, Werth VP, Williams KJ.

Ann Rheum Dis. 2019 Apr 20. pii: annrheumdis-2019-215505. doi: 10.1136/annrheumdis-2019-215505. [Epub ahead of print] No abstract available.

PMID:
31005899
11.

Advancing understanding, diagnosis, and therapies for cutaneous lupus erythematosus within the broader context of systemic lupus erythematosus.

Chen KL, Krain RL, Werth VP.

F1000Res. 2019 Mar 25;8. pii: F1000 Faculty Rev-332. doi: 10.12688/f1000research.17787.1. eCollection 2019. Review.

12.

Evaluating cutaneous lupus disease activity endpoints and their effects on quality of life as an outcome measure for clinical trials.

Tarazi M, Gaffney RG, Feng R, Werth VP.

Br J Dermatol. 2019 Mar 28. doi: 10.1111/bjd.17926. [Epub ahead of print]

PMID:
30920654
13.

Relative risk of microscopic colitis in dermatomyositis.

Pearson DR, Werth VP.

J Am Acad Dermatol. 2019 Mar 22. pii: S0190-9622(19)30463-3. doi: 10.1016/j.jaad.2019.03.045. [Epub ahead of print] No abstract available.

PMID:
30910660
14.

Effect of in vivo Hydroxychloroquine and ex vivo Anti-BDCA2 mAb Treatment on pDC IFNα Production From Patients Affected With Cutaneous Lupus Erythematosus.

Gardet A, Pellerin A, McCarl CA, Diwanji R, Wang W, Donaldson D, Franchimont N, Werth VP, Rabah D.

Front Immunol. 2019 Feb 21;10:275. doi: 10.3389/fimmu.2019.00275. eCollection 2019.

15.

Practice-based differences in paediatric discoid lupus erythematosus.

Arkin LM, Buhr K, Brandling-Bennett H, Chiu Y, Chong B, Curran M, Hunt R, Paller AS, Werth VP, Klein-Gitelman M, von Scheven E, Ardalan K.

Br J Dermatol. 2019 Feb 15. doi: 10.1111/bjd.17780. [Epub ahead of print]

PMID:
30768778
16.

Examining cutaneous disease activity as an outcome measure for clinical trials in dermatomyositis.

Gaffney RG, Feng R, Pearson DR, Tarazi M, Werth VP.

J Am Acad Dermatol. 2019 Jun;80(6):1793-1794. doi: 10.1016/j.jaad.2019.01.028. Epub 2019 Jan 24. No abstract available.

PMID:
30685266
17.

Monoclonal antibody targeting BDCA2 ameliorates skin lesions in systemic lupus erythematosus.

Furie R, Werth VP, Merola JF, Stevenson L, Reynolds TL, Naik H, Wang W, Christmann R, Gardet A, Pellerin A, Hamann S, Auluck P, Barbey C, Gulati P, Rabah D, Franchimont N.

J Clin Invest. 2019 Mar 1;129(3):1359-1371. doi: 10.1172/JCI124466. Epub 2019 Feb 18.

18.

Supplementing Dermatology Physician Resident Education in Vasculitis and Autoimmune Connective Tissue Disease: A Prospective Study of an Online Curriculum.

Haemel A, Kahl L, Callen J, Werth VP, Fiorentino D, Fett N.

JAMA Dermatol. 2019 Jan 9. doi: 10.1001/jamadermatol.2018.4837. [Epub ahead of print] No abstract available.

PMID:
30624565
19.

Anifrolumab effects on rash and arthritis: impact of the type I interferon gene signature in the phase IIb MUSE study in patients with systemic lupus erythematosus.

Merrill JT, Furie R, Werth VP, Khamashta M, Drappa J, Wang L, Illei G, Tummala R.

Lupus Sci Med. 2018 Nov 26;5(1):e000284. doi: 10.1136/lupus-2018-000284. eCollection 2018.

20.

Evaluating results of an interferon-γ release assay in patients with autoimmune disease who are taking hydroxychloroquine.

Gaffney RG, Werth VP.

J Am Acad Dermatol. 2019 Apr;80(4):1162-1164. doi: 10.1016/j.jaad.2018.12.027. Epub 2018 Dec 21. No abstract available.

PMID:
30582995
21.

Bullous pemphigoid in adolescence.

Patsatsi A, Kyriakou A, Werth VP.

Pediatr Dermatol. 2019 Mar;36(2):184-188. doi: 10.1111/pde.13717. Epub 2018 Dec 19. Review.

PMID:
30569520
22.

The diagnosis and classification of amyopathic dermatomyositis: a historical review and assessment of existing criteria.

Concha JSS, Tarazi M, Kushner CJ, Gaffney RG, Werth VP.

Br J Dermatol. 2019 May;180(5):1001-1008. doi: 10.1111/bjd.17536. Epub 2019 Feb 25. Review.

PMID:
30561064
23.

Perspective From the 5th International Pemphigus and Pemphigoid Foundation Scientific Conference.

Lee J, Werth VP, Hall RP 3rd, Eming R, Fairley JA, Fajgenbaum DC, Harman KE, Jonkman MF, Korman NJ, Ludwig RJ, Murrell DF, Musette P, Naik HB, Sadik CD, Yamagami J, Yale ML, Payne AS.

Front Med (Lausanne). 2018 Nov 8;5:306. doi: 10.3389/fmed.2018.00306. eCollection 2018.

24.

Lichen Planus Pigmentosus and Frontal Fibrosing Alopecia Mimicking Discoid Lupus Erythematosus.

Kushner CJ, Concha JSS, Pearson DR, Werth VP.

Arthritis Rheumatol. 2019 Mar;71(3):478. doi: 10.1002/art.40779. Epub 2019 Feb 1. No abstract available.

PMID:
30427589
25.

Alopecias in lupus erythematosus.

Concha JSS, Werth VP.

Lupus Sci Med. 2018 Oct 25;5(1):e000291. doi: 10.1136/lupus-2018-000291. eCollection 2018.

26.

Large International Validation of ABSIS and PDAI Pemphigus Severity Scores.

Hébert V, Boulard C, Houivet E, Duvert Lehembre S, Borradori L, Della Torre R, Feliciani C, Fania L, Zambruno G, Camaioni DB, Didona B, Marinovic B, Schmidt E, Schumacher N, Hünefeld C, Schanz S, Kern JS, Hofmann S, Bouyeure AC, Picard-Dahan C, Prost-Squarcioni C, Caux F, Alexandre M, Ingen-Housz-Oro S, Bagot M, Tancrede-Bohin E, Bouaziz JD, Franck N, Vabres P, Labeille B, Richard MA, Delaporte E, Dupuy A, D'Incan M, Quereux G, Skowro F, Paul C, Livideanu CB, Beylot-Barry M, Doutre MS, Avenel-Audran M, Bedane C, Bernard P, Machet L, Maillard H, Jullien D, Debarbieux S, Sassolas B, Misery L, Abasq C, Dereure O, Lagoutte P, Ferranti V, Werth VP, Murrell DF, Hertl M, Benichou J, Joly P; French Study Group on Autoimmune Bullous Skin Diseases; Autoimmune Bullous Skin Disease Task Force of the European Academy of Dermatology and Venereology.

J Invest Dermatol. 2019 Jan;139(1):31-37. doi: 10.1016/j.jid.2018.04.042. Epub 2018 Oct 6. Review.

PMID:
30301637
27.

Fatigue in systemic lupus erythematosus and other autoimmune skin diseases.

Tarazi M, Gaffney RG, Pearson D, Kushner CJ, Werth VP.

Br J Dermatol. 2019 Jun;180(6):1468-1472. doi: 10.1111/bjd.17257. Epub 2018 Nov 22.

PMID:
30269332
28.

Efficacy and safety of ustekinumab, an IL-12 and IL-23 inhibitor, in patients with active systemic lupus erythematosus: results of a multicentre, double-blind, phase 2, randomised, controlled study.

van Vollenhoven RF, Hahn BH, Tsokos GC, Wagner CL, Lipsky P, Touma Z, Werth VP, Gordon RM, Zhou B, Hsu B, Chevrier M, Triebel M, Jordan JL, Rose S.

Lancet. 2018 Oct 13;392(10155):1330-1339. doi: 10.1016/S0140-6736(18)32167-6. Epub 2018 Sep 21.

PMID:
30249507
29.

Advances in Cutaneous Lupus Erythematosus and Dermatomyositis: A Report from the 4th International Conference on Cutaneous Lupus Erythematosus-An Ongoing Need for International Consensus and Collaborations.

Concha JSS, Patsatsi A, Marshak-Rothstein A, Liu ML, Sinha AA, Lee LA, Merola JF, Jabbari A, Gudjonsson JE, Chasset F, Jarrett P, Chong B, Arkin L, Fernandez AP, Caproni M, Greenberg SA, Kim HJ, Pearson DR, Femia A, Vleugels RA, Fiorentino D, Fujimoto M, Wenzel J, Werth VP.

J Invest Dermatol. 2019 Feb;139(2):270-276. doi: 10.1016/j.jid.2018.08.017. Epub 2018 Sep 19. No abstract available.

PMID:
30243657
30.

Increased Myeloid Dendritic Cells and TNF-α Expression Predicts Poor Response to Hydroxychloroquine in Cutaneous Lupus Erythematosus.

Zeidi M, Kim HJ, Werth VP.

J Invest Dermatol. 2019 Feb;139(2):324-332. doi: 10.1016/j.jid.2018.07.041. Epub 2018 Sep 15.

PMID:
30227141
31.

Subacute cutaneous lupus erythematosus and systemic lupus erythematosus associated with abatacept.

Tarazi M, Aiempanakit K, Werth VP.

JAAD Case Rep. 2018 Aug 16;4(7):698-700. doi: 10.1016/j.jdcr.2018.03.008. eCollection 2018 Aug. No abstract available.

32.

Acute onset/flares of dermatomyositis following ingestion of IsaLean herbal supplement: Clinical and immunostimulatory findings.

Zeidi M, Chansky PB, Werth VP.

J Am Acad Dermatol. 2019 Mar;80(3):801-804. doi: 10.1016/j.jaad.2018.08.019. Epub 2018 Aug 27. No abstract available.

PMID:
30165168
33.

Prevalence of Pruritus in Cutaneous Lupus Erythematosus: Brief Report of a Multicenter, Multinational Cross-Sectional Study.

Samotij D, Szczęch J, Kushner CJ, Mowla MR, Dańczak-Pazdrowska A, Antiga E, Chasset F, Furukawa F, Hasegawa M, Hashizume H, Islam A, Ikeda T, Lesiak A, Polańska A, Misery L, Szepietowski JC, Tsuruta D, Adamski Z, Werth VP, Reich A.

Biomed Res Int. 2018 Jul 25;2018:3491798. doi: 10.1155/2018/3491798. eCollection 2018.

34.

Systemic sclerosis: Current concepts of skin and systemic manifestations.

Pearson DR, Werth VP, Pappas-Taffer L.

Clin Dermatol. 2018 Jul - Aug;36(4):459-474. doi: 10.1016/j.clindermatol.2018.04.004. Epub 2018 Apr 12. Review.

PMID:
30047430
35.

Evaluation of the reliability and validity of the Cutaneous Lupus Erythematosus Disease Area and Severity Index (CLASI) in paediatric cutaneous lupus among paediatric dermatologists and rheumatologists.

Kushner CJ, Tarazi M, Gaffney RG, Feng R, Ardalan K, Brandling-Bennett HA, Castelo-Soccio L, Chang JC, Chiu YE, Gmuca S, Hunt RD, Kahn PJ, Knight AM, Mehta J, Pearson DR, Treat JR, Wan J, Yeguez AC, Concha JSS, Patel B, Okawa J, Arkin LM, Werth VP.

Br J Dermatol. 2019 Jan;180(1):165-171. doi: 10.1111/bjd.17012. Epub 2018 Oct 5.

PMID:
30033560
36.

Drug-induced dermatomyositis after lacosamide: A case report.

Gaffney RG, Tarazi M, Werth VP.

JAAD Case Rep. 2018 Jun 13;4(6):584-585. doi: 10.1016/j.jdcr.2018.03.009. eCollection 2018 Jul. No abstract available.

37.

Natural history of disease activity and damage in patients with cutaneous lupus erythematosus.

Ker KJ, Teske NM, Feng R, Chong BF, Werth VP.

J Am Acad Dermatol. 2018 Dec;79(6):1053-1060.e3. doi: 10.1016/j.jaad.2018.06.040. Epub 2018 Jun 30.

38.

Lasting pathologic complete response to chemotherapy for ovarian cancer after receiving antimalarials for dermatomyositis.

Cadena I, Werth VP, Levine P, Yang A, Downey A, Curtin J, Muggia F.

Ecancermedicalscience. 2018 May 22;12:837. doi: 10.3332/ecancer.2018.837. eCollection 2018.

39.

Disease severity and prophylactic measures in patients with cutaneous lupus erythematosus: results of a worldwide questionnaire-based study.

Samotij D, Szczęch J, Werth VP, Furukawa F, Kuhn A, Szepietowski JC, Reich A.

Postepy Dermatol Alergol. 2018 Apr;35(2):192-198. doi: 10.5114/ada.2018.75242. Epub 2018 Apr 24.

40.

Lupus community panel proposals for optimising clinical trials: 2018.

Merrill JT, Manzi S, Aranow C, Askenase A, Bruce I, Chakravarty E, Chong B, Costenbader K, Dall'Era M, Ginzler E, Hanrahan L, Kalunian K, Merola J, Raymond S, Rovin B, Saxena A, Werth VP.

Lupus Sci Med. 2018 Mar 23;5(1):e000258. doi: 10.1136/lupus-2018-000258. eCollection 2018. Review. Erratum in: Lupus Sci Med. 2018 Jun 11;5(1):e000258corr1.

41.

Classification of myositis.

Lundberg IE, de Visser M, Werth VP.

Nat Rev Rheumatol. 2018 May;14(5):269-278. doi: 10.1038/nrrheum.2018.41. Epub 2018 Apr 12. Review.

PMID:
29651121
42.

Itch in dermatomyositis: the role of increased skin interleukin-31.

Kim HJ, Zeidi M, Bonciani D, Pena SM, Tiao J, Sahu S, Werth VP.

Br J Dermatol. 2018 Sep;179(3):669-678. doi: 10.1111/bjd.16498. Epub 2018 Jun 21.

PMID:
29494763
43.

Diagnosis and Management of Pemphigus: recommendations by an International Panel of Experts.

Murrell DF, Peña S, Joly P, Marinovic B, Hashimoto T, Diaz LA, Sinha AA, Payne AS, Daneshpazhooh M, Eming R, Jonkman MF, Mimouni D, Borradori L, Kim SC, Yamagami J, Lehman JS, Saleh MA, Culton DA, Czernik A, Zone JJ, Fivenson D, Ujiie H, Wozniak K, Akman-Karakaş A, Bernard P, Korman NJ, Caux F, Drenovska K, Prost-Squarcioni C, Vassileva S, Feldman RJ, Cardones AR, Bauer J, Ioannides D, Jedlickova H, Palisson F, Patsatsi A, Uzun S, Yayli S, Zillikens D, Amagai M, Hertl M, Schmidt E, Aoki V, Grando SA, Shimizu H, Baum S, Cianchini G, Feliciani C, Iranzo P, Mascaró JM Jr, Kowalewski C, Hall R, Groves R, Harman KE, Marinkovich MP, Maverakis E, Werth VP.

J Am Acad Dermatol. 2018 Feb 10. pii: S0190-9622(18)30207-X. doi: 10.1016/j.jaad.2018.02.021. [Epub ahead of print]

44.

Treatment of Autoimmune Bullous Disorders in Pregnancy.

Kushner CJ, Concha JSS, Werth VP.

Am J Clin Dermatol. 2018 Jun;19(3):391-403. doi: 10.1007/s40257-018-0342-0. Review.

PMID:
29392620
45.

Computerized planimetry to assess clinical responsiveness in a phase II randomized trial of topical R333 for discoid lupus erythematosus.

Presto JK, Okon LG, Feng R, Wallace DJ, Furie R, Fiorentino D, Werth VP.

Br J Dermatol. 2018 Jun;178(6):1308-1314. doi: 10.1111/bjd.16337. Epub 2018 Apr 17.

PMID:
29336019
46.

Dermatomyositis: A diagnostic dilemma.

Da Silva DM, Patel B, Werth VP.

J Am Acad Dermatol. 2018 Aug;79(2):371-373. doi: 10.1016/j.jaad.2017.12.074. Epub 2018 Jan 5. No abstract available.

PMID:
29309821
47.

Chemoprevention of Basal and Squamous Cell Carcinoma With a Single Course of Fluorouracil, 5%, Cream: A Randomized Clinical Trial.

Weinstock MA, Thwin SS, Siegel JA, Marcolivio K, Means AD, Leader NF, Shaw FM, Hogan D, Eilers D, Swetter SM, Chen SC, Jacob SE, Warshaw EM, Stricklin GP, Dellavalle RP, Sidhu-Malik N, Konnikov N, Werth VP, Keri JE, Robinson-Bostom L, Ringer RJ, Lew RA, Ferguson R, DiGiovanna JJ, Huang GD; Veterans Affairs Keratinocyte Carcinoma Chemoprevention Trial (VAKCC) Group.

JAMA Dermatol. 2018 Feb 1;154(2):167-174. doi: 10.1001/jamadermatol.2017.3631.

48.

Applicability of EULAR/ACR classification criteria for dermatomyositis to amyopathic disease.

Patel B, Khan N, Werth VP.

J Am Acad Dermatol. 2018 Jul;79(1):77-83.e1. doi: 10.1016/j.jaad.2017.12.055. Epub 2017 Dec 29.

PMID:
29291954
49.

The systemic management of cutaneous dermatomyositis: Results of a stepwise strategy.

Anyanwu CO, Chansky PB, Feng R, Carr K, Okawa J, Werth VP.

Int J Womens Dermatol. 2017 Jun 13;3(4):189-194. doi: 10.1016/j.ijwd.2017.05.001. eCollection 2017 Dec.

50.

Importance of recognition and improved treatment for antimelanoma differentiation-associated protein 5-associated dermatomyositis.

Caplan A, Imadojemu S, Werth VP.

Br J Dermatol. 2017 Nov;177(5):1168-1169. doi: 10.1111/bjd.15944. No abstract available.

Supplemental Content

Loading ...
Support Center